Medsin UCL

support our statement on UCL's access policy

The UAEM campaign here at UCL has started a petition to encourage our University to improve accesss to essential medicines. We need YOUR help to make a difference. Please read our petition 'statement' below and add your name to it.

Statement for Equitable Access to Medicines and Medical Technologies Developed at University College London

Every year approximately 10 million people die because they don't have access to existing essential medicines and vaccines (WHO, 2004).

In conjunction with the grand challenge of Global Health the UCL research strategy states that, 'With its unique strengths and position, UCL has an opportunity and an obligation to develop and disseminate original knowledge to help provide solutions to the grand challenges faced by the world today and tomorrow.' (UCL, 2008 p.1)

We agree with this statement and believe that UCL, as a world-ranked and globally aware research university, is advantageously placed to have a positive impact.

We believe that medicines and medical technologies researched and developed at UCL should be accessible to the poorest members of society in lower and middle income countries (as classified by the World Bank).

To achieve this we support licensing terms, such as those in the Global Access Licensing Framework (UAEM, 2010), that make provisions for generic production of medicines and medical technologies developed at UCL in lower and middle-income countries.

see current signatures>>

REFERENCES

More information can be found on the Universities Allied for Essential Medicines international website, http://essentialmedicine.org.

UAEM (2010) Global Access Licensing Framework.
http://essentialmedicine.org/archive/global-access-licensing-framework-galf-v20 accessed online 14/10/2010
University College London (2008) UCL Research Strategy: Maximising Impact and Influence Globally.
http://www.ucl.ac.uk/research/images/research-strategy-2008.pdf accessed online 13/10/2010
World Health Organisation (2004) Equitable access to essential medicine: a framework for collective action. Geneva, WHO.
World Bank (2010) Country and Lending Groups.
http://data.worldbank.org/about/country-classifications/country-and-lending-groups accessed online 13/10/2010

last updated : october 25th 2010